Summary
- Current Price
- As of today, PRQR price is $1.90, down -3.55% on
- Current Price All-Time High
- PRQR price is currently -93.12% below its historical high of $27.60 set on
- Market Cap
- PRQR current market cap is $268M, up +23.56% over the past 365 days
- Revenue
- PRQR current annual revenue is $17.95M, down -12.22% year-over-year
- Next Earnings
- The next earnings release for PRQR is on
Profile
| Metric | Value |
|---|---|
| Full Name | ProQR Therapeutics N.V. |
| Ticker | NASDAQ: PRQR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Netherlands |
| IPO | |
| Indexes | Not included |
| Website | proqr.com |
| Employees | 166 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.90 | ||
| Price, 1D Change | -3.55% | |
| $268M | ||
| - | ||
| - | ||
| 1.79 | ||
| $17.95M | ||
| Revenue, 1Y Change | -12.22% | |
| -$0.45 | ||
| EPS, 1Y Change | -29.59% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.45 | ||
| EPS Estimate | -$0.61 | N/A |
| EPS Est. Change | -33.85% | N/A |
| $17.95M | ||
| Revenue Estimate | $15.31M | N/A |
| Revenue Est. Change | -14.71% | N/A |
| $1.90 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.50 | -$0.35 | +30.10% | |
| -$0.49 | -$0.45 | +7.30% | |
| -$0.61 | N/A | -33.85% | |
| -$0.68 | N/A | -50.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $22.07M | $20.45M | -7.33% | |
| $19.75M | $17.95M | -9.11% | |
| $15.31M | N/A | -14.71% | |
| $16.22M | N/A | -9.66% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -7.77% | ||
| +25.83% | ||
| +23.56% | ||
| +119.39% | ||
| -12.22% | ||
| +375.25% | ||
| -29.59% | ||
| +52.17% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.90 | ||
| $1.83 | ||
| $1.68 | ||
| $1.79 | ||
| $1.72 | ||
| $0.04 | ||
| 1.79 | ||
| $0.13 | ||
| 58.35 | ||
| 66.38% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $17.95M | ||
| -$0.45 | ||
| $14.90M | ||
| 83.01% | ||
| -$49.53M | ||
| -275.91% | ||
| -$47.61M | ||
| -265.21% | ||
| -$46.48M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.28 | ||
| 3.09 | ||
| 3.09 | ||
| - | ||
| 1 | ||
| -4.02 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 17.27 | ||
| 6.19 | ||
| -3.75 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $57.99M | ||
| $108.53M | ||
| $132.43M | ||
| $117.59M | ||
| $74.44M | ||
| $38.10M | ||
| $16.43M | ||
| $5.22M | ||
| $350.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $65.56M | ||
| $64.43M | ||
| $3.05M | ||
| $0.00 | ||
| $3.05M | ||
| $0.00 | ||
| $21.40K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$59.58M | ||
| -$1.15M | ||
| -$2.07M | ||
| $1.15M | ||
| -$60.73M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Evercore ISI Group | → | |
| Jones Trading | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| JMP Securities | → | |
| Cantor Fitzgerald | → | |
| Oppenheimer | → | |
| Evercore ISI Group |
Analyst sentiment
Institutional ownership
Screeners with PRQR
FAQ
- What is the ticker symbol for ProQR Therapeutics N.V.?
- The ticker symbol for ProQR Therapeutics N.V. is NASDAQ:PRQR
- Does ProQR Therapeutics N.V. pay dividends?
- No, ProQR Therapeutics N.V. does not pay dividends
- What sector is ProQR Therapeutics N.V. in?
- ProQR Therapeutics N.V. is in the Healthcare sector
- What industry is ProQR Therapeutics N.V. in?
- ProQR Therapeutics N.V. is in the Biotechnology industry
- What country is ProQR Therapeutics N.V. based in?
- ProQR Therapeutics N.V. is headquartered in Netherlands
- When did ProQR Therapeutics N.V. go public?
- ProQR Therapeutics N.V. initial public offering (IPO) was on September 18, 2014
- Is ProQR Therapeutics N.V. in the S&P 500?
- No, ProQR Therapeutics N.V. is not included in the S&P 500 index
- Is ProQR Therapeutics N.V. in the NASDAQ 100?
- No, ProQR Therapeutics N.V. is not included in the NASDAQ 100 index
- Is ProQR Therapeutics N.V. in the Dow Jones?
- No, ProQR Therapeutics N.V. is not included in the Dow Jones index
- When was ProQR Therapeutics N.V. last earnings report?
- ProQR Therapeutics N.V.'s most recent earnings report was on May 12, 2026
- When does ProQR Therapeutics N.V. report earnings?
- The next expected earnings date for ProQR Therapeutics N.V. is August 6, 2026
Data Sources & References
- PRQR Official Website www.proqr.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1612940/000110465926026713/0001104659-26-026713-index.htm
- PRQR Profile on Yahoo Finance finance.yahoo.com/quote/PRQR
- PRQR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/prqr
